We have elicited a reliable Raman spectral signature for glucose in rabbit aqueous humor across mammalian physiological ranges in a rabbit model stressed by recent myocardial infarction. The technique employs near infrared Raman laser excitation at 785 nm, multivariate analysis, non-linear artificial neural networks and an offset spectra subtraction strategy. Aqueous humor glucose levels ranged from 37 to 323 mg/dL. Data were obtained in 80 UL samples to anticipate the volume constraints imposed by the human and rabbit anterior chamber of the eye. Total sample collection time was 10 seconds with total power delivered to sample of 30 Mw. Spectra generated from the aqueous humor were compared qualitatively to artificial aqueous samples and an excitation offset technique was devised to counteract broadband background noise partially obscuring the glucose signature. Feature extraction and data analysis were accomplished using second order Savitsky-Golay derivatives, linear multivariate analysis (partial least squares fit) and non-linear (artificial neural network) techniques. Predicted glucose levels correlated well with expected glucose concentration (R2= 0.98, n=32) .
INTRODUCTION
Non-invasive measurement of glucose metabolism by any method (including optical spectroscopy techniques) remains an elusive goal. Blood and most excreted fluids contain numerous optically active and fluorescing substances capable of obscuring glucose spectral signatures. Aqueous humor (AH) filling the anterior chamber of the eye between the lens and the cornea, however, contains relatively few optically active molecules. These are primarily glucose, lactate, ascorbate, and urea.' Glucose concentration in AH appears linearly related to plasma glucose levels in animal studies and the rate constant for transport of glucose into AH from the plasma is not affected by diabetes.* Lactate and urea levels in AH appear to vary with blood levels, while ascorbate is concentrated in AH by active transport mechanisms. These facts, combined with a spectroscopically accessible location behind the relatively optically clear cornea make AH a reasonable site to attempt non-invasive analysis of glucose metabolism.
The potential for non-invasive estimation of blood glucose employing Raman spectroscopy on AH has been previously suggested.3 Preliminary work has demonstrated that mixtures of the primary AH metabolites can be distinguished from one another in water solution^.^ Techniques have been described to hopefully increase Raman sensitivity and allow the measurement of these metabolites at laser intensities commiserate with in vivo safety constraints.516. Reliable measurement of glucose at physiologic levels and under physiological conditions with Raman spectroscopy has only recently been described.'~~ The goals of this study are to determine whether Raman spectra extracted from rabbit aqueous humor can provide a reliable measure of glucose concentration across ranges commonly encountered in hypoglycemic, healthy, and diabetic states; (2) the obscuring effect of broadband background apparent in AH samples can be eliminated using a spectral excitation offset strategy in combination with multivariate and artificial neural network signal processing algorithms; and, (3) simple non-linear artificial neural network techniques can generate a Bayesian probability estimating the reliability of a single sample measurement. Figure 1 . This flow chart for signal acquisition and processing depicts the production of Raman spectra with excitation at either 785nm or at an offset (785+&), smoothing accomplished using a Savisky-Golay second derivative, determination of optimal correlation regions in the spectral set, and delivery of multifactor analysis output to the input layer of a non-linear ANN. The ANN configuration is the original backpropagation algorithm with linear feature extraction accomplished by the direct input from input nodes to output and the non-linear component extracted by a hidden layer node. In this case the final output produces a non-linear least squares fit to the data. The addition of a second output node and the creation of two discrete classes for glucose levels (e.g., normal and hyperglycemic) converts the algorithm to a Bayesian estimator. In this case the ANN calculates the probability that a particular vector belongs to either of the two classes.
analysates can dramatically alter glucose estimation.
A multivariate analysis and neural network strategy adequately extracted the glucose signature from such solutions.
When glucose, lactate, ascorbate, and urea were mixed at concentrations approximating normal levels, the composite Raman signature evidenced marked similarity to that of the rabbit AH. However, the rabbit spectra also contained evidence of broadband fluorescence and elevated lactate activity.
Partial compensation for such activity can be obtained using standard first and second derivative techniques, such as the well-known Savitsky-Golay algorithm employed in this study. A more direct experimental approach of great utility involves acquiring two spectra for each sample. The first is obtained with an excitation frequency of, in our case, 785nm. The excitation wavelength is then offset slightly (with power adjusted to maintain a constant sample exposure). The offset is empirically determined to resolve the most prominent spectral line for the system. In our samples this was the urea line at 1002 cm-l. The subtraction of these two spectra. nulls the confounding broadband activity and converts true spectral peaks to biphasic signatures.
MUTIVARIATE ANALYSIS -The difficulties inherent in identifying and quantifying individual components of biological mixtures using Raman spectral analysis are well-documented and have spawned a wide variety of multivariate analysis techniques. For our multivariate algorithm we have chosen the partial least squares (PLS) technique, an analysis and spectral decomposition algorithm that, unlike principal component analysis (PCA), uses concentration information to calculate the eigenvectors.
In our design, test and training samples were put into a "round-robin" or autocorrellation training mode to iteratively employ a l l but one of the sample set in the minimization and eigenvector extraction process. Hence, the system trains on all but one of the samples, estimates the glucose level in that sample, then rotates the test sample back into the general pool and repeats the cycle until all samples have served as an unknown test subject. where the learning coefficient, q, and the momentum, a, control the rate of learning (these depend primarily on data set size and the roughness of the solution landscape.
To train a network, we divide an initial data set into training vectors and test vectors. For small data sets it is best to sequentially pull a single vector for testing, train on the remainder, test against the unknown, and then iteratively repeat the process N times for a data set on N vectors. In this way every vector is tested without ever being seen by the algorithm during training. The total number of weights in the ANN, W, should be less than the total training set size N, (W<N). Larger networks will simply memorize the training set, act as a lookup table, and perform poorly when presented with novel samples. ANN output through a single node produces a non-linear least squares fit to the data In this study, the net trains against the predicted glucose levels using nine PLS factor scores and then estimates the unknown glucose level.
In this study we have employed the classical backpropagation configuration identified by Rumelhart, et al.15 with the input nodes (plus a bias node) connecting both directly to the output node and indirectly via an intermediate hidden layer (see Figure 1 ) . This configuration, often overlooked, simplifies analysis of the linear (input directly to output) and first order nonlinear (input to hidden to output) contributions to the least squares fit. Specifically for this effort we employed an ANN with nine input nodes, a single node in the hidden layer, and a single output for a [9p;l,l] algorithm (where "p" denotes the connection of the prior or input layer directly to the output). Notice this configuration provides a total of 21 weights (9 input + 1 bias connected to 1 hidden and 1 output, plus 1 weight connecting the hidden and output nodes).
Since the random initial setting of the weights make this a stochastic process, multiple restarts can provide statistical data on the accuracy of the output. In clinical usage it is critical that we supply an assessment of the reliability of a specific measurement. Such an estimate is often not available with statistical constraints only applying to the sample set as a whole and providing little information about a particular case. Multivariate analysis and the superset, artificial neural networks, provide techniques for acquiring this information. One such strategy employs an ANN to estimate the Bayesian probability of the correct classification of a sample vector into a discrete class of vectors, e.g. hypoglycemic, normal, or hypoglycemic.
BAYESIAN PROBABILITIES -ANN output can either b e single node to provide a non-linear lest squares fit to a continuous dataset, or multi-nodal to provide discrete classifications. An ANN employed using a sigmoidal transfer function in 2-node output format produces t h e Bayesian a posterion' probability of correct classification.l6 For example, if the two nodes produce outputs of 0.9 and 0.1 for classes A and B, the ANN is reporting a 90% probability for the vector to be a member of class A. As a check of system function, note that the outputs should sum to 1 . To illustrate the technique we modified the above ANN using four PLS by Princeton Instruments and Galactic Industries Corporation, respectively. The integration time for each spectra was 10 seconds with an average power delivered to sample of 30mW. Spectra were first obtained using 785 nm excitation, then repeated after de-tuning the frequency sufficient to offset the pronounced spectral peak for urea (1 0 0 2~m -~) to produce a smooth biphasic signature while simultaneously nulling out the broadband interference.
A cross-correlational analysis of the original and offset spectra generated identified 15 regions correlating significantly (R2>0.4) with expected glucose concentration. This made it possible to implement a partial least squares algorithm for data reduction and calibration using fewer test measurements than data samples. This is particularly important when attempting to build a robust spectral prediction algorithm capable of iwithdtanding the effect of multi-metabolite concentration variance on spectral signatures. If a classification algorithm employs more test measurements (in our case, spectral bins) than data points, the algorithm will simply memorize the data and serve as a lookup table. The algorithm will correctly quantify the samples used to train it, but have poor results generalizing to new data sets. Our ability to identify a subset of spectral regions significantly correlated with metabolite concentration levels allowed us to decrease the number of input features from 3200 to less than the number of metabolite samples.
RESULTS AND DISCUSSION
To assess the capability of three signal processing strategies in a more nearly in vivo regimen, we lowered sample exposure time to 10 seconds and power delivered to sample to 30 mW. Special designed quartz cells, open to the Raman microscope probe, were employed to allow excitation of 80 UL volume of rabbit AH at 785nm, mimicking the geometric Constraints imposed by an in vivo assay. AH samples were taken within 10 to 60 seconds following experiment termination by cardiac extraction. The samples were then frozen for transport to our laboratory. Immediately prior to obtaining Raman signatures, the samples were warmed to room temperature and glucose levels, [G]e, measured using a Bayer Elite Clinical Glucometer. Figure   2 demonstrates the predictive ability of the current system. For a l l three strategies we first examined the correlation coefficients for a l l spectral regions and identified 1 5 spectral regions with R2 > 0.4 for use with PLS-1 during initial feature extraction. Such a strategy significantly diminished the degrees of freedom in the algorithm search from 3200 spectral bins to 389. Next, a l l spectra were smoothed using Savitsky-Golay second derivative across 49 points. Figure 2 b shows the result of obtaining a second set of spectra by de-tuning from 785nm sufficient to shift Raman signatures the width of the prominent urea peak (power to sample was maintained at 30mW). This produces an excitation offset spectra. Subtraction of the primary and offset spectra results in a set of difference spectra capable of improving /# to 0.90. Finally, Figure 2c demonstrates the effect of using the offset spectra strategy and initial feature extraction by the linear PLS-1 algorithm, then employing a non-linear ANN to generate the final glucose estimate.
In this case the correlation between [Gel, and [Go] improves to 0.98. Fig 2a) . Detuning from 785nm sufficient to shift Raman signatures the width of the prominent urea peak while maintaining power to sample at 30mW produces an excitation offset spectra. Subtraction of the primary and offset spectra results in a set of difference spectra capable of improving #to 0.90. Figure 2c demonstrates the effect of using the offset spectra strategy and initial feature extraction by the linear PLS-1 algorithm, then employing a non-linear ANN to generate the final glucose estimate. In this case the correlation between [Gd, and [Go] improves to 0.98. Collection time for each sample was 10 seconds and the resulting spectra were pre-processed using the Savitsky-Golay second derivative algorithm.
To increase the potential clinical utility of this system we investigated a strategy for assessing the reliability of a specific measurement. Recall that ANN output can either be single node to provide a non-linear lest squares fit to the dataset, or multi-nodal to provide discrete classifications. We reconfigured our ANN using a sigmoidal transfer function in 2-node output format to produce the Bayesian a posteriori probability of correct classification for a single sample into one of two discrete classes. To set. In a clinical setting such a discrepancy would serve as an appreciated warning that the data need to be re-obtained to resolve the conflict.
CONCLUSION
In this study we have demonstrated (1) Raman spectra extracted from rabbit aqueous humor can provide a reliable measure of glucose concentration across ranges commonly encountered in hypoglycemic, healthy, and diabetic states; (2) the obscuring effect of broadband background apparent in AH samples can be eliminated using a spectral excitation offset strategy in combination with multivariate and artificial neural network signal processing algorithms; and, (3) simple non-linear artificial neural network techniques can generate a Bayesian probability estimating the reliability of a single sample measurement.
We find these initial results most encouraging and agree with others that Raman spectroscopy of aqueous humor in the near infrared combined with multifactor analysis techniques constitutes a new technology capable of estimating levels of blood glucose and perhaps other metabolites by non-invasive analysis of AH.
The rabbit AH signature in this initial study may also be complicated by the optical activity of the drugs introduced as part of surgical intervention and the cardiovascular experimental procedure. Potential Raman-active molecules include aspirin, ketamine, xylazine, pentobarbital, and heparin. We' are currently investigating the Raman response of these and several other potentially confounding substances.
R is of note in passing but beyond the scope of this article, that our blood and AH glucose level measurements confirm the previously reported elevated glucose levels in rabbit AH in response to xylazine and is the subject of an ongoing investigation. Xylazine is commonly utilized in conjunction with ketamine as an anesthetic in veterinary surgical procedures. It We are currently proceeding to determine the minimum laser power and data acquisition time required for in vivo application. We expect that clinical utility of this methodology will require another order of magnitude reduction in power and integration time below current levels of 30mW and 10s. We suspect 1 mW and 1s will be the gold standard for clinical acceptance of this technology. Studies are currently underway to elucidate the temporal correlation between glucose levels in AH and blood concentrations in a rabbit model.
